BOULDER, Colo., Nov 15, 2001 /PRNewswire via COMTEX/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E.
Conway, will speak at the Robertson Stephens Medical Conference on November 29
in New York City. The public is welcome to listen to the presentation as a
webcast on the company's website after November 30.
Event: Robertson Stephens Medical Conference
Presentation by: Robert E. Conway, Chief Executive Officer,
Array BioPharma
Date: Thursday, November 29, 2001
Time: 9:00 a.m. Eastern Time
Webcast: www.arraybiopharma.com
About Array BioPharma
Array BioPharma is a drug discovery company creating new drugs through the
integration of chemistry, structural biology and informatics. Array collaborates
with leading pharmaceutical and biotechnology companies to identify novel small
molecule drugs and leverages the Array Discovery Platform to develop its own
pipeline of proprietary drug candidates. The Array scientific team has a proven
track record of success in identifying promising drug candidates.
Note: This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve significant
risks and uncertainties, including those discussed below and described more
fully in reports filed by Array with the Securities and Exchange Commission,
including our Annual Report on Form 10-K as filed on September 27, 2001. Because
these statements reflect our current expectations concerning future events, our
actual results could differ materially from those anticipated in these
forward-looking statements as a result of many factors. These factors include,
but are not limited to, our ability to achieve and maintain profitability, the
extent to which the pharmaceutical and biotechnology industries are willing to
collaborate with third parties on their drug discovery activities, the ability
of our collaborators and of Array to meet drug discovery objectives tied to
milestones and royalties, and our ability to attract and retain experienced
scientists and management. We are providing this information as of November 15,
2001. We undertake no duty to update any forward-looking statements to reflect
the occurrence of events or circumstances after the date of such statements or
of anticipated or unanticipated events that alter any assumptions underlying
such statements.
Array BioPharma's press releases are available at www.arraybiopharma.com .
For further information please contact: Tricia Haugeto of Array BioPharma Inc.,
+1-303-386-1193, thaugeto@arraybiopharma.com
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193,
thaugeto@arraybiopharma.com
